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Over  the  last  two  decades,  evidence  and  systematic
review  have  been  the  keystones  of  guideline  develop-
ment.  Evidence-based  medicine  was  deﬁned  by  Sacket
et  al.  as  ‘‘the  conscientious,  explicit,  and  judicious  use
of  current  best  evidence  in  making  decisions  about  the
care  of  individual  patients’’.1 This  practice  of  evidence-
based  medicine  means  integrating  individual  clinical
expertise  with  the  best  available  external  clinical  evi-
dence  from  systematic  research.  The  GRADE  approach
(http://www.gradeworkinggroup.org)  points  to  the  impor-
tance  of  an  estimate  of  the  intervention  effect  and  the
conﬁdence  that  the  estimate  is  correct,  and  was  the  ﬁrst
to  stress  the  balance  of  desirable  and  undesirable  effects.
Over  20  organizations,  including  the  World  Health  Organiza-
tion  (WHO),  the  BMJ,  and  the  Cochrane  Collaboration  have
adopted  the  GRADE  system.  In  the  last  decade,  the  Appraisal
of  Guidelines  for  Research  &  Evaluation  (AGREE)  Instrument
(http://www.agreetrust.org)  was  developed  to  address  the
quality  of  practice  guidelines  in  a  systematic  way.
Several  evidence-based  guidelines  have  been  devel-
oped  within  otorhinolaryngology,  both  at  national  and
international  levels.2--4 However,  we  are  still  far  from
evidence-based  practice  in  our  daily  work.5,6 Although  it
has  been  shown  that  adhering  to  guidelines  signiﬁcantly
improves  the  quality  of  life  of  our  patients,  there  has  also
been  ample  proof  that  adherence  to  guidelines  is  often
insufﬁcient.7 This  editorial  attempts  to  evaluate  poten-
tial  reasons  why  we  do  not  use  guidelines  as  much  as  we
should.
One  of  the  major  issues  is  that  we  are  still  not  able
to  develop  worldwide  guidelines;  there  can  be  signiﬁcant
difference  in  the  guidelines  on  the  same  topics  produced
by  different  countries.  Aarts  et  al.  demonstrated  that  the
guidelines  on  a  similar  topic  may  show  dissimilarities  regard-
ing  conclusions,  levels  of  evidence,  and  citations  used.8 This Please cite this article as: Fokkens W,  Pundir V. Guidelines
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educes  the  credibility  of  such  guidelines.  Although  we  are
ware  of  differences  in  health  care  systems,  it  is  imperative
o  have  guidelines  that  are  methodologically  impeccable,
re  acknowledged  worldwide,  and  that  account  for  potential
egional  differences.  Thus,  currently  when  using  guidelines,
he  clinician  has  to  personally  ascertain  their  quality.  The
GREE  instrument  is  a  useful  aid  in  this  aspect.
Moreover,  the  clinician  has  to  realize  that  often  the  evi-
ence  on  which  the  guidelines  are  based  is  not  overwhelming
nd  in  some  situations  a  high  level  of  evidence  is  very  dif-
cult  or  impossible  to  achieve.  For  instance,  the  number
f  randomized  surgical  trials  is  expected  to  remain  very
imited.  When  evidence  is  scarce  and/or  of  limited  qual-
ty,  the  authors  of  guidelines  often  try  to  advise  based  on
he  limited  evidence  available,  but  the  limitations  of  their
oundations  are  often  not  appreciated  when  elaborate  diag-
ostic  or  treatment  schemes  are  presented.  The  opposite  is
lso  often  true:  guidelines  may  give  the  answers  to  a  long
ist  of  questions  without  providing  guidance  and  orientation,
aking  them  very  difﬁcult  to  read  and  digest,  thus  ham-
ering  their  use  in  daily  practice.  Finally,  when  treating  our
atients  it  is  important  to  realize  that  the  available  evidence
ay  be  accumulated  in  a  different  population  group  than
hat  of  the  patient:  trials  often  exclude  patients  with  cer-
ain  characteristics,  such  as  smokers,  children  and  patients
ver  65,  or  pregnant  woman.
Lastly,  we  should  keep  in  mind  that  medicine  is  an  ever-
volving  ﬁeld.  Guidelines  are  updated  regularly  in  light  of
ew  evidence  and  we  must  ensure  that  we  use  the  latest
uidelines  in  our  daily  practice.
If  the  reader  interprets  this  editorial  as  an  argument
gainst  using  guidelines,  he/she  is  mistaken.  Guidelines  are
 great  help  in  our  daily  practice  and  provide  support  for
hose  who  are  not  willing  or  able  to  study  all  available
iterature.  In  most  countries,  deliberately  deviating  from
uidelines  has  to  be  acknowledged  in  the  patient  notes
nd  justiﬁed  for  good  reason.  However,  we  have  to  avoid
o  using  a  guideline  as  a  cookbook  for  our  patients  and
lways  remember  the  wise  words  of  Sacket:  ‘‘Evidence-
ased  medicine  is  the  conscientious,  explicit,  and  judicious
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